|
|
| DRD1_PIG |
DRD1 |
D(1A) dopamine receptor |
5.378e-77 |
1.00
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
1.818e-35 |
1.00
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
8.822e-28 |
1.00
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
1.144e-27 |
1.00
|
| DRD4_RAT |
Drd4 |
D(4) dopamine receptor |
1.401e-71 |
0.63
|
| CP2J2_HUMAN |
CYP2J2 |
Cytochrome P450 2J2 |
3.678e-68 |
0.35
|
| Q4DCQ3_TRYCC |
|
Superoxide dismutase |
1.127e-53 |
0.39
|
| CCR1_HUMAN |
CCR1 |
C-C chemokine receptor type 1 |
6.519e-53 |
0.40
|
| ZN664_CAVPO |
ZNF664 |
Zinc finger protein 664 |
1.552e-50 |
0.63
|
| THB_HUMAN |
THRB |
Thyroid hormone receptor beta |
9.719e-44 |
0.40
|
| 5HT2A_MACMU |
HTR2A |
5-hydroxytryptamine receptor 2A |
7.545e-40 |
0.32
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
1.515e-38 |
0.63
|
| DPOLM_HUMAN |
POLM |
DNA-directed DNA/RNA polymerase mu |
7.142e-37 |
0.29
|
| TDT_BOVIN |
DNTT |
DNA nucleotidylexotransferase |
7.142e-37 |
0.29
|
| 5HT7R_MOUSE |
Htr7 |
5-hydroxytryptamine receptor 7 |
1.244e-34 |
0.43
|
| 5HT2A_PIG |
HTR2A |
5-hydroxytryptamine receptor 2A |
4.238e-33 |
0.63
|
| H10_HUMAN |
H1-0 |
Histone H1.0 |
2.078e-32 |
0.63
|
| PA24A_BOVIN |
PLA2G4A |
Cytosolic phospholipase A2 |
8.619e-29 |
0.35
|
| HRH3_RAT |
Hrh3 |
Histamine H3 receptor |
2.673e-27 |
0.47
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
5.076e-27 |
0.41
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
1.19e-26 |
0.68
|
| 5HT2C_RAT |
Htr2c |
5-hydroxytryptamine receptor 2C |
1.776e-26 |
0.63
|
| PLD2_HUMAN |
PLD2 |
Phospholipase D2 |
2.204e-25 |
0.36
|
| HRH2_HUMAN |
HRH2 |
Histamine H2 receptor |
6.485e-24 |
0.63
|
| POLI_MOUSE |
Poli |
DNA polymerase iota |
9.719e-24 |
0.29
|
| MCHR1_RAT |
Mchr1 |
Melanin-concentrating hormone receptor 1 |
1.16e-23 |
0.55
|
| US28_HCMVA |
US28 |
G-protein coupled receptor homolog US28 |
6.05e-23 |
0.33
|
| PA2GA_RABIT |
PLA2G2A |
Phospholipase A2, membrane associated |
6.377e-23 |
0.28
|
| 5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
8.598e-23 |
0.63
|
| SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
1.835e-22 |
0.41
|
| 5HT2A_HUMAN |
HTR2A |
5-hydroxytryptamine receptor 2A |
1.873e-22 |
0.63
|
| 5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
1.223e-20 |
0.63
|
| ERG2_YEAST |
ERG2 |
C-8 sterol isomerase |
1.705e-20 |
0.63
|
| 5HT5A_MOUSE |
Htr5a |
5-hydroxytryptamine receptor 5A |
3.5e-20 |
0.38
|
| CASB_RAT |
Csn2 |
Beta-casein |
2.25e-19 |
0.43
|
| KCNK2_HUMAN |
KCNK2 |
Potassium channel subfamily K member 2 |
2.265e-19 |
0.63
|
| 5HT2C_HUMAN |
HTR2C |
5-hydroxytryptamine receptor 2C |
2.657e-19 |
0.63
|
| DRD5_HUMAN |
DRD5 |
D(1B) dopamine receptor |
4.558e-19 |
0.63
|
| PLD1_HUMAN |
PLD1 |
Phospholipase D1 |
1e-18 |
0.36
|
| AP2S1_RAT |
Ap2s1 |
AP-2 complex subunit sigma |
3.972e-18 |
0.63
|
| SGMR2_RAT |
Tmem97 |
Sigma intracellular receptor 2 |
6.29e-18 |
0.63
|
| S1PR2_RAT |
S1pr2 |
Sphingosine 1-phosphate receptor 2 |
6.543e-18 |
0.35
|
| EBP_HUMAN |
EBP |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
1.83e-17 |
0.63
|
| VACHT_RAT |
Slc18a3 |
Vesicular acetylcholine transporter |
2.498e-17 |
0.63
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
3.956e-17 |
0.63
|
| DRD3_CHLAE |
DRD3 |
D(3) dopamine receptor |
4.502e-17 |
0.63
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
4.902e-17 |
0.40
|
| 5HT1A_HUMAN |
HTR1A |
5-hydroxytryptamine receptor 1A |
1.11e-16 |
0.63
|
| 5HT2A_CANLF |
HTR2A |
5-hydroxytryptamine receptor 2A |
1.11e-16 |
0.32
|
| NK2R_MOUSE |
Tacr2 |
Substance-K receptor |
1.11e-16 |
0.31
|
| PA2GA_HUMAN |
PLA2G2A |
Phospholipase A2, membrane associated |
1.11e-16 |
0.32
|
| 5HT3B_MOUSE |
Htr3b |
5-hydroxytryptamine receptor 3B |
2.22e-16 |
0.41
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
7.772e-16 |
0.59
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
1.11e-15 |
0.63
|
| THA_HUMAN |
THRA |
Thyroid hormone receptor alpha |
1.443e-15 |
0.40
|
| OXER1_HUMAN |
OXER1 |
Oxoeicosanoid receptor 1 |
1.998e-15 |
0.30
|
| POLH_HUMAN |
POLH |
DNA polymerase eta |
2.22e-15 |
0.29
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
2.887e-15 |
0.63
|
| 5HT7R_RAT |
Htr7 |
5-hydroxytryptamine receptor 7 |
3.109e-15 |
0.63
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
3.997e-15 |
0.63
|
| SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
6.55e-15 |
0.63
|
| DRD1_RAT |
Drd1 |
D(1A) dopamine receptor |
7.216e-15 |
0.68
|
| 5HT2B_RAT |
Htr2b |
5-hydroxytryptamine receptor 2B |
2.343e-14 |
0.37
|
| MURB_STAAU |
murB |
UDP-N-acetylenolpyruvoylglucosamine reductase |
6.095e-14 |
0.34
|
| NLRP1_HUMAN |
NLRP1 |
NACHT, LRR and PYD domains-containing protein 1 |
1.842e-13 |
0.29
|
| DRD5_RAT |
Drd5 |
D(1B) dopamine receptor |
3.253e-13 |
0.39
|
| MURA_ECOLI |
murA |
UDP-N-acetylglucosamine 1-carboxyvinyltransferase |
1.128e-12 |
0.34
|
| 5HT2B_HUMAN |
HTR2B |
5-hydroxytryptamine receptor 2B |
1.49e-12 |
0.63
|
| DRD1_HUMAN |
DRD1 |
D(1A) dopamine receptor |
5.332e-12 |
0.63
|
| POLK_HUMAN |
POLK |
DNA polymerase kappa |
5.743e-12 |
0.29
|
| GNAI1_HUMAN |
GNAI1 |
Guanine nucleotide-binding protein G(i) subunit alpha-1 |
1.196e-11 |
0.28
|
| GNAI3_HUMAN |
GNAI3 |
Guanine nucleotide-binding protein G(i) subunit alpha |
1.196e-11 |
0.28
|
| CALM_BOVIN |
CALM |
Calmodulin |
1.92e-11 |
0.31
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
8.301e-11 |
0.63
|
| DRD2_CHLAE |
DRD2 |
D(2) dopamine receptor |
8.876e-11 |
0.63
|
| GNAO_HUMAN |
GNAO1 |
Guanine nucleotide-binding protein G(o) subunit alpha |
1.336e-10 |
0.28
|
| MURB_ECOLI |
murB |
UDP-N-acetylenolpyruvoylglucosamine reductase |
1.409e-10 |
0.40
|
| CP74A_ARATH |
CYP74A |
Allene oxide synthase, chloroplastic |
6.69e-10 |
0.29
|
| SGMR2_HUMAN |
TMEM97 |
Sigma intracellular receptor 2 |
6.935e-10 |
0.63
|
| PA2GA_RAT |
Pla2g2a |
Phospholipase A2, membrane associated |
1.045e-09 |
0.28
|
| ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
1.831e-09 |
0.63
|
| ADA2B_HUMAN |
ADRA2B |
Alpha-2B adrenergic receptor |
4.349e-09 |
0.63
|
| SSR5_MOUSE |
Sstr5 |
Somatostatin receptor type 5 |
6.195e-09 |
0.30
|
| CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
1.674e-08 |
0.35
|
| SSR5_HUMAN |
SSTR5 |
Somatostatin receptor type 5 |
1.941e-08 |
0.30
|
| Q63380_RAT |
NET |
Transporter |
2.03e-08 |
0.63
|
| DHB3_HUMAN |
HSD17B3 |
Testosterone 17-beta-dehydrogenase 3 |
2.273e-08 |
0.37
|
| DPOLL_HUMAN |
POLL |
DNA polymerase lambda |
2.8e-08 |
0.29
|
| 5HT4R_RAT |
Htr4 |
5-hydroxytryptamine receptor 4 |
3.973e-08 |
0.31
|
| MPIP2_HUMAN |
CDC25B |
M-phase inducer phosphatase 2 |
5.359e-08 |
0.33
|
| ADA2C_HUMAN |
ADRA2C |
Alpha-2C adrenergic receptor |
5.371e-08 |
0.63
|
| NK2R_RAT |
Tacr2 |
Substance-K receptor |
6.11e-08 |
0.31
|
| CCR3_RAT |
Ccr3 |
C-C chemokine receptor type 3 |
7.515e-08 |
0.29
|
| S1PR2_HUMAN |
S1PR2 |
Sphingosine 1-phosphate receptor 2 |
1.213e-07 |
0.35
|
| DRD3_RAT |
Drd3 |
D(3) dopamine receptor |
1.872e-07 |
0.63
|
| 5HT5A_HUMAN |
HTR5A |
5-hydroxytryptamine receptor 5A |
1.977e-07 |
0.34
|
| PA2G5_MOUSE |
Pla2g5 |
Calcium-dependent phospholipase A2 |
2.994e-07 |
0.28
|
| HRH1_RAT |
Hrh1 |
Histamine H1 receptor |
7.446e-07 |
0.63
|
| PA2GA_MOUSE |
Pla2g2a |
Phospholipase A2, membrane associated |
1.166e-06 |
0.28
|
| HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
1.32e-06 |
0.34
|
| MCHR1_HUMAN |
MCHR1 |
Melanin-concentrating hormone receptor 1 |
1.632e-06 |
0.55
|
| DPOLB_RAT |
Polb |
DNA polymerase beta |
3.559e-06 |
0.29
|
| CA2D1_RAT |
Cacna2d1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
3.628e-06 |
0.31
|
| ADA1A_BOVIN |
ADRA1A |
Alpha-1A adrenergic receptor |
4.06e-06 |
0.63
|
| PLD1_RAT |
Pld1 |
Phospholipase D1 |
4.342e-06 |
0.30
|
| S1PR5_HUMAN |
S1PR5 |
Sphingosine 1-phosphate receptor 5 |
5.597e-06 |
0.40
|
| ADA1A_RAT |
Adra1a |
Alpha-1A adrenergic receptor |
5.784e-06 |
0.63
|
| ADA2A_HUMAN |
ADRA2A |
Alpha-2A adrenergic receptor |
6.518e-06 |
0.63
|
| SC6A4_HUMAN |
SLC6A4 |
Sodium-dependent serotonin transporter |
7.795e-06 |
0.63
|
| 5HT4R_HUMAN |
HTR4 |
5-hydroxytryptamine receptor 4 |
8.504e-06 |
0.31
|